FINDINGS Cancer genomics experts at City of Hope®, one of the largest cancer res...
Selecta Biosciences is embarking on a strategic collaboration with Cartesian, st...
After last year’s nod, AstraZeneca’s flagship PD-L1 Imfinzi is demonstrating eff...
Swiss biotech Nouscom has raised €67.5m ($72m) in a Series C funding round co-l...
Concerns have been raised over the suitability of current FDA-approved treatmen...
AstraZeneca has announced its strategy for the cardiometabolic market, in parti...
The Phase II interim data shows ProKidney’s autologous cell therapy React (...
South Korea has been busy with a series of reforms that aim to accelerate the t...
The pharmaceutical industry is already highly competitive. It's a business driv...
Teva Pharmaceuticals has entered a partnership with Royalty Pharma to expedite ...
Novartis Pharma has signed an exclusive worldwide licence agreement for Leg...
Orphelia Pharma is taking action to drive regulatory agencies like the European...
Telix Pharmaceuticals has signed a conditional non-binding term sheet to acquir...
The American Medical Association Monday called on insurance companies, employers...
A small and preliminary study published Monday seems to indicate that patients r...
Ohio has enshrined the right to an abortion. But major obstacles remain for pati...
